On March 12, 2019 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need, reported that management will participate in four investor conferences in March, including the 31st Annual ROTH Conference in Laguna Niguel, California, the Oppenheimer 29th Annual Healthcare Conference in New York City, the Oppenheimer’s Biotech Summit by the Lake at Northwestern University in Evanston, Illinois, and the ROTH Battle of NASH Thrones Spring Investor Conference in New York City (Press release, CymaBay Therapeutics, MAR 12, 2019, View Source [SID1234534243]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

31st Annual ROTH Conference
Date: Monday, March 18
Time: 9:30am Pacific Time
Format: Panelist: Why Knowing NASH as a Generalist Can Make You Rich in 2019

Time: 12:00pm Pacific Time
Format: Fireside Chat
Webcast: View Source

Oppenheimer 29th Annual Healthcare Conference
Date: Tuesday, March 19
Time: 8:35am Eastern Time
Format: Fireside Chat
Webcast: View Source

Oppenheimer’s Biotech Summit by the Lake
Date: Wednesday, March 27
Time: 1:00pm Central Time
Format: Corporate Presentation

ROTH Battle of NASH Thrones Spring Investor Conference
Date: Thursday, March 28
Time: 8:00 am Eastern Time
Format: Panel: 12 Months of Data – 2019 Is the Year for FXR and PPAR Clinical Readouts

Time: 4:00pm Eastern Time
Format: Panel: Why MRI May Hold the Key to the Kingdom in Diagnosis and Drug Development